CIK 0001549595 · Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270838048
- Phone
- (415) 660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +2,858 | 80,838 | ||
| 2025-10-30 | Hansen Gwenn Chief Scientific Officer | Sale | −4,087 | $12.80 | $52K | 76,751 |
| 2025-10-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −3,207 | 3,207 | ||
| 2025-10-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −2,000 | 4,000 | ||
| 2025-10-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −3,750 | 22,500 | ||
| 2025-10-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −2,858 | 28,584 | ||
| 2025-10-14 | Hansen Gwenn Chief Scientific Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2025-09-17 | GREGORY JULIA P Director | Option exercise | +10,750 | $1.86 | $20K | 10,750 |
| 2025-09-17 | GREGORY JULIA P Director | Option exercise · Director Stock Option (right to buy) | −10,750 | 22,583 | ||
| 2025-08-01 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −5,402 | $11.03 | $60K | 35,512 |
| 2025-07-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,886 | 36,610 | ||
| 2025-07-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,000 | 38,610 | ||
| 2025-07-30 | van Houte Hans Chief Financial Officer | Option exercise | +3,750 | 42,360 | ||
| 2025-07-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,858 | 45,218 | ||
| 2025-07-30 | van Houte Hans Chief Financial Officer | Sale | −4,304 | $12.01 | $52K | 40,914 |
| 2025-07-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,886 | 5,773 | ||
| 2025-07-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,000 | 6,000 | ||
| 2025-07-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −3,750 | 26,250 | ||
| 2025-07-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,858 | 31,442 | ||
| 2025-07-30 | Ring Christine Chief Legal Officer | Option exercise | +1,924 | 39,242 |
Page 11 of 20 · 381 trades